Lyxor Msci China Ucits Etf is a equity ETF from Amundi tracking the Multi Units Luxembourg - Lyxor Msci China index through physical replication. Domiciled in Luxembourg and launched in 2018, the fund manages about 609 M € and charges a TER of 0.29% — 29 € per year on a €10,000 investment. Income is automatically reinvested in the fund (accumulating).
Lyxor Msci China Ucits Etf competes with 34 other products in the same class and region (Equity, China): it ranks 10th by fund size and 12th by ongoing cost, with a TER of 0.29% against a group median of 0.40%. It has been listed since 2018, 8 years of track record.
On a €10,000 investment the TER costs 29 € a year, against 40 € for the median product in the category.
Replication is physical: the fund holds the underlying securities directly.
Income is accumulated: no distribution is paid out, the share price absorbs it. In a savings plan this removes the need to reinvest dividends by hand. The fund is denominated in EUR. That is not the same as currency risk: the exposure comes from the currencies of the underlying holdings, not from the denomination or the trading currency of a given listing.
The fund is domiciled in Luxembourg, which determines the tax treatment of income received by the fund and the supervisory authority.
| Borsa Italiana | LCCN | EUR |
| XETRA | L4K3 | EUR |
| Francoforte | L4K3 | EUR |
| London Stock Exchange | LCCN | USD |
| Euronext Paris | LCCN | EUR |
| SIX Swiss Exchange | LCCN | CHF |
Source: the fund's KID and the issuer's official documentation — data verified as of July 2026.
This page is informational and is not an investment recommendation. Figures may contain errors or be out of date: always check the KID and the issuer's factsheet before any decision.